{"organizations": [], "uuid": "ba3c7acb87a815329e16f6345448df147751b695", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-aslan-pharmaceuticals-files-for-pr/brief-aslan-pharmaceuticals-files-for-proposed-ipo-in-u-s-idUSFWN1R80ZU", "country": "US", "domain_rank": 408, "title": "BRIEF-‍Aslan Pharmaceuticals Files For Proposed IPO In U.S.​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.06, "site_type": "news", "published": "2018-03-27T09:27:00.000+03:00", "replies_count": 0, "uuid": "ba3c7acb87a815329e16f6345448df147751b695"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-aslan-pharmaceuticals-files-for-pr/brief-aslan-pharmaceuticals-files-for-proposed-ipo-in-u-s-idUSFWN1R80ZU", "ord_in_thread": 0, "title": "BRIEF-‍Aslan Pharmaceuticals Files For Proposed IPO In U.S.​", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "aslan pharmaceuticals", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "aslan pharmaceuticals ltd", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Aslan Pharmaceuticals Ltd:\n* ‍ASLAN PHARMACEUTICALS FILES FOR PROPOSED INITIAL PUBLIC OFFERING IN U.S.​\n* ‍ASLAN HAS APPLIED TO LIST ITS ADSS ON NASDAQ GLOBAL MARKET UNDER TRADING SYMBOL “ASLN”​\n* ‍LEERINK PARTNERS AND PIPER JAFFRAY & CO. ARE ACTING AS JOINT BOOK-RUNNING MANAGERS FOR THIS OFFERING​ Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T09:27:00.000+03:00", "crawled": "2018-03-27T11:52:33.040+03:00", "highlightTitle": ""}